Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aricept SR 23 mg in moderate to severe Alzheimer's disease
NCT00566501Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Dec 2007; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00566501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566501.